Robaei Daniel, Ford Thomas, Ooi Sze-Yuan
Eastern Heart Clinic, Prince of Wales Hospital, Barker Street Randwick NSW, Australia; University of New South Wales, Randwick NSW, Australia.
Eastern Heart Clinic, Prince of Wales Hospital, Barker Street Randwick NSW, Australia; University of New South Wales, Randwick NSW, Australia.
Heart Lung Circ. 2015 Feb;24(2):e31-4. doi: 10.1016/j.hlc.2014.09.013. Epub 2014 Sep 30.
Ankyrin-B protein is involved in regulating expression and localisation of cardiac ion channels and transporters. Mutations of the ANK2 gene in the rare condition Ankyrin-B syndrome result in loss of function of the ankyrin-B protein which in turn leads to abnormal regulation of intracellular sodium and calcium and a predisposition to cardiac arrhythmia including torsades de pointes. We describe a rare case of this condition characterised by sinus node dysfunction, atrial fibrillation and prolonged QT syndrome in a young patient with a family history of sudden death. The management of Ankyrin-B syndrome may include avoidance of QT prolonging medications, insertion of a permanent pacemaker for sinus node dysfunction, or a cardioverter defibrillator for those at high-risk of sudden death from torsades de pointes.
锚蛋白B参与调节心脏离子通道和转运体的表达与定位。罕见的锚蛋白B综合征中ANK2基因的突变会导致锚蛋白B功能丧失,进而导致细胞内钠和钙的调节异常,并易引发包括尖端扭转型室速在内的心律失常。我们描述了该疾病的一例罕见病例,其特征为一名有猝死家族史的年轻患者出现窦房结功能障碍、心房颤动和长QT综合征。锚蛋白B综合征的治疗可能包括避免使用延长QT间期的药物、为窦房结功能障碍植入永久性起搏器,或为有尖端扭转型室速猝死高风险的患者植入心脏复律除颤器。